GRI Bio, Inc.
GRI
$1.80
-$0.20-10.00%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 23.01% | 9.21% | 15.11% | 17.22% | -1.99% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -3.51% | 16.36% | 45.42% | 35.62% | 19.90% |
| Operating Income | 3.51% | -16.36% | -45.42% | -35.62% | -19.90% |
| Income Before Tax | 3.50% | -16.45% | -45.66% | -36.07% | -20.91% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 3.50% | -16.45% | -45.66% | -36.07% | -20.91% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 3.50% | -16.45% | -45.66% | -36.07% | -20.91% |
| EBIT | 3.51% | -16.36% | -45.42% | -35.62% | -19.90% |
| EBITDA | 3.50% | -16.37% | -45.44% | -35.63% | -19.91% |
| EPS Basic | 87.67% | 77.12% | -12.78% | -- | -- |
| Normalized Basic EPS | 83.34% | 68.01% | -123.42% | -- | -- |
| EPS Diluted | 87.67% | 77.12% | -12.78% | -- | -- |
| Normalized Diluted EPS | 83.34% | 68.01% | -123.42% | -- | -- |
| Average Basic Shares Outstanding | 2,802.09% | 4,346.56% | 2,139.43% | -- | -- |
| Average Diluted Shares Outstanding | 2,802.09% | 4,346.56% | 2,139.43% | -- | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |